These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3159208)

  • 1. Medical prevention of ischemic stroke.
    Barnett HJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():247-55. PubMed ID: 3159208
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acetylsalicylic acid in the treatment of ischemic cerebrovascular disorders].
    Caneschi S; Bonaventi C; Finzi F; Tito P
    Minerva Med; 1986 Jun; 77(27):1299-308. PubMed ID: 3523307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici M; Mattle HP; Rothwell PM;
    Cerebrovasc Dis; 2009; 27(6):608-13. PubMed ID: 19407444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and the prevention of stroke after transient ischaemic attack.
    Warlow C
    Monogr Atheroscler; 1986; 14():203-6. PubMed ID: 3526126
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of stroke.
    Barnett HJ
    Int Anesthesiol Clin; 1984; 22(3):11-29. PubMed ID: 6384054
    [No Abstract]   [Full Text] [Related]  

  • 6. Stroke therapy: status of anti-platelet aggregation drugs.
    Yatsu FM
    Neurology; 1977 Jun; 27(6):503-4. PubMed ID: 325429
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
    Bousser MG
    J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke].
    Brechter C; Bäcklund H; Krook H; Müller R; Nitelius E; Olsson JE; Olsson O; Thornberg A
    Lakartidningen; 1980 Dec; 77(52):4947-56. PubMed ID: 7010029
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin for transient ischemic attacks.
    Med Lett Drugs Ther; 1980 Aug; 22(17):71-2. PubMed ID: 6995822
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
    Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V
    J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial].
    Guiraud-Chaumeil B; Rascol A; David J; Boneu B; Clanet M; Bierme R
    Rev Neurol (Paris); 1982; 138(5):367-85. PubMed ID: 6815756
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks.
    Grundmann K; Jaschonek K; Kleine B; Dichgans J; Topka H
    J Neurol; 2003 Jan; 250(1):63-6. PubMed ID: 12527994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary prevention of TIA and stroke. How much must thrombocytes not be inhibited?].
    Einecke D
    MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366495
    [No Abstract]   [Full Text] [Related]  

  • 15. [Atrial fibrillation and apoplexy--risks and prevention].
    Koefoed BG; Gulløv AL; Petersen P
    Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant and platelet-antiaggregating therapy in stroke and threatened stroke.
    Dyken ML
    Neurol Clin; 1983 Feb; 1(1):223-42. PubMed ID: 6390149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
    Smith EE; Cannon CP; Murphy S; Feske SK; Schwamm LH
    Am Heart J; 2006 Feb; 151(2):338-44. PubMed ID: 16442896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex difference in the antiplatelet effect of aspirin in patients with stroke.
    Cavallari LH; Helgason CM; Brace LD; Viana MA; Nutescu EA
    Ann Pharmacother; 2006 May; 40(5):812-7. PubMed ID: 16608908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.